Search Results

You are looking at 1 - 10 of 10 items for :

  • "continuous manufacturing" x
Clear All

volume assets more appropriately fit into a pilot plant infrastructure, which is often not as readily available or in short supply in manufacturing. Continuous manufacturing (CM) offers a unique cost-effective solution to this problem since these products

Open access

Optimizing current chemical processes alone does not yield the improvements required in the fine chemical and pharmaceutical industries. At least partially, a switch from batch to continuous manufacturing is needed. Cost-, time-, and atom-efficient routes frequently demand the application of high temperatures, pressures, and concentrations, and/or the use of highly reactive reagents. These chemistries often cannot be employed in conventional reactors. Costly and long alternative synthetic routes are chosen instead. The application of continuous-flow microreactors allows to access “harsh” or “hazardous” reaction conditions and, furthermore, enables entirely new transformations.

Open access

pharmaceutical industry where the increased potency of new active pharmaceutical ingredients (APIs) means that smaller quantities of drug are required to deliver the desired therapeutic outcome [ 1 ]. In addition, continuous manufacturing limits the risk of large

Open access

intermediates/starting materials; – number of steps translated to continuous manufacturing; – possibility to telescope the synthesis; – benefits obtained compared to the batch process; – multipurpose facilities. A few additional comments should be added

Open access

continuous manufacturing process in 2016 for Janssen's HIV-1 treatment drug Prezista [ 2 , 9 ]. Despite the growing importance of biocatalysis and microscale technology, merging of these two fields took much slower pace than implementation of

Open access

. Ponnappa , M. Collot , D. Kopetzki , D. T. McQuade , P. H. Seeberger * Organic Letters 2014 , 16 , 1794 – 1797 . “ Development of a multi-step synthesis and workup sequence for an integrated, continuous manufacturing process

Open access

Introduction Continuous processing has a long history in the production of chemicals at bulk scale. In fact, the majority of bulk chemicals is being produced in a continuous manufacturing process. However, batchwise production

Open access

to continuous manufacturing has been applied effectively by the pharmaceutical industry for small molecule drugs. Continuous applications for biologics manufacturing on the other hand have their limitations due to the complexity of automation and

Open access

, A. A. Kulkarni Organic Process Research & Development 2015 , 19 , 1138 – 1147 “ Oscillatory flow reactors (OFRs) for continuous manufacturing and crystallization ” T. McGlone , N. E. B. Briggs , C. A. Clark , C. J

Restricted access

this can be done for any molecule, but the automated synthesis of specific compound libraries [52], active pharmaceutical ingredients [53], or even the end-to-end continuous manufacturing of certain pharmaceuticals is indeed possible [54]. Furthermore

Open access